Koxitor 90 is a selective COX-2 inhibitor formulated to support the management of moderate to severe inflammatory pain associated with musculoskeletal and joint disorders.
The softgel delivery system is designed to assist in consistent absorption while supporting physician-directed therapy in inflammatory conditions affecting mobility and comfort.
Category : Tablets & Capsules
Get a QuoteKoxitor 90 contains Etoricoxib, a selective cyclooxygenase-2 (COX-2) inhibitor indicated for inflammatory pain management.
Etoricoxib selectively inhibits the COX-2 enzyme responsible for the synthesis of prostaglandins involved in inflammation and pain signaling. By targeting this pathway, the formulation helps reduce inflammatory responses while maintaining gastrointestinal tolerability compared to non-selective NSAIDs.
The softgel capsule format is designed for convenient oral administration as part of supervised clinical management.
Composition
Etoricoxib 90 mg Capsules (Softgel)
Intended Use
Koxitor 90 Capsules are intended for the management of:
Treatment should be initiated based on clinical assessment and prescribed by a registered healthcare professional.
| Property | Details |
|---|---|
| Dosage Form: | Softgel Capsule |
| Therapeutic Category: | Selective COX-2 Inhibitor / NSAID |
| Pack Size: | 10 × 10 Blister |
| Route of Administration: | Oral |
| Brand: | Servochem |
